# A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)

> **NCT00132769** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 106 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** MK-0873
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00132769
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132769, "A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00132769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*